Related Experiment Video
Updated: Jan 17, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Therapeutic Plasmapheresis in a Tertiary Pediatric Intensive Care Unit: A 10-Year Single-Center Experience
Abdullah Akkuş1, Ahmet Osman Kılıç1, Nefise Betül Ercan2
1Department of Pediatrics, Faculty of Medicine, Necmettin Erbakan University, Konya, Türkiye.
Insights
Therapeutic plasmapheresis (TP) is a vital supportive therapy for critically ill children in the pediatric intensive care unit (PICU). Early TP initiation may be life-saving for conditions like septic shock and MIS-C.
Area of Science:
- Pediatric Critical Care Medicine
- Extracorporeal Therapies
Background:
- Therapeutic plasmapheresis (TP) is an extracorporeal treatment for diverse diseases.
- Its application in pediatric intensive care units (PICUs) warrants further investigation.
Purpose of the Study:
- To evaluate the utilization and outcomes of therapeutic plasmapheresis in a pediatric intensive care unit.
- To identify common indications, complications, and mortality rates associated with TP in critically ill children.
Main Methods:
- Retrospective study of pediatric patients receiving TP between 2013 and 2023.
- Data collected from medical records of patients admitted to the PICU.
Main Results:
- 72 children received TP; common indications were septic shock and multisystem inflammatory syndrome in children (MIS-C).
- Median TP sessions were 2, median PRISM III score was 14.5.
- Mortality rate was 44.4%, with complications including thrombosis in 5.6%.
Conclusions:
- Therapeutic plasmapheresis serves as crucial supportive therapy for critically ill pediatric patients.
- Early initiation of TP, guided by appropriate indications, may improve survival rates.
Introduction:
Therapeutic plasmapheresis (TP) is an extracorporeal treatment method used for a variety of patients with various diseases.
Methods:
For this retrospective study, patients who were admitted to the pediatric intensive care unit (PICU) and received TP therapy between 2013 and 2023, and whose medical records were reached, were included.
Results:
A total of 72 children were included in the study. The most common indication for TP was septic shock, followed by multisystem inflammatory syndrome in children (MIS-C). The median number of TP sessions was 2, and the median PRISM III score was 14.5. Of the patients, 56.9% had ASFA class 3 diagnoses, and 5.6% developed thrombosis as a complication. The mortality rate was 44.4%, most of whom had an underlying disease.
Conclusion:
TP is an important supportive therapy in critically ill patients admitted to PICUs. We believe that early initiation of TP may be life-saving with proper indications.
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
Pharmacokinetics in Pediatric Patients: Drug Excretion
Venous Thrombosis III: Interprofessional Care
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

